We recently published a list of 15 Stocks That Stole The Show Last Week. In this article, we are going to take a look at ...

Shares of Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) are trading higher after the company, in collaboration with MIT, ...

At more than two petabytes, and across more than 10 million different biological contexts, Recursion’s data is the world’s largest image-based dataset designed specifically for the development ...

The images and data were acquired using ... noise and improves sharpness, Recursion achieved excellent image quality of complex morphological structures—all at the speed of widefield imaging ...

SALT LAKE CITY - Recursion ... model's utility in processing microscopy data for life science applications. OpenPhenom-S/16 is trained on over three million images from public datasets, including ...

Recursion Pharmaceuticals leverages AI and machine learning to revolutionize drug discovery, reducing costs and accelerating development, positioning itself as a leader in tech-driven biopharma.

Recursion, a drug discovery startup out of Salt Lake City, Utah has announced a $60 million Series B round, led by Data Collective ... Instead, it uses that image-based approach to look at ...

Recursion is expected to meet with the U.S. Food and Drug Administration to discuss plans for an additional clinical study. More data and feedback from the FDA would be required to "figure out a ...